Volume 5 Number 2

Website Exclusive Contents!
Exclusive contents: images and/or videos
• Coronary dissection healing patterns: from complete resolution to restenosis. Insights from optical coherence tomography (CTO)
• Early cardiac perforation after percutaneous closure of a patent foramen ovale
Editorial
26
EuroIntervention and EuroPCR 2009. A truly "Grand Cru"

Serruys PW

EuroIntervention 2009;5:167

27
Transcatheter Aortic Valve Implantation. Where are we?

de Jaegere P, Ruiz C, Bonhoeffer P, Vahanian A, Marco J, Serruys PW

EuroIntervention 2009;5:169-171

EAPCI column
28
Notes on clubs and the forming of group identity

Wijns W

EuroIntervention 2009;5:173-175

Focus article
29
Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting

García-García H, Mintz G, Lerman A, Vince G, Margolis P, Van Es G-A, Morel M, Nair A, Virmani R, Burke A, Stone G, Serruys PW

EuroIntervention 2009;5:177-189

Clinical research
30
Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)

Routledge H, Lefèvre T, Colombo A, Oldroyd K, Hamm C, Guagliumi G, von Scheidt W, Guetta V, Ruzyllo W, Wittebols K, Goedhart D, Serruys PW

EuroIntervention 2009;5:190:196

31
Long-term outcome after the V stenting technique in de novo bifurcation lesions using drug-eluting stents

Girasis C, Onuma Y, Wong C, Kukreja N, van Domburg R, Serruys PW

EuroIntervention 2009;5:197-205

32
Ovalum CiTop™ Expander™: a novel guidewire for crossing coronary chronic total occlusions – first-in-man (FIM) experience

Parikh K, Shah A, Chag M, Segev A

EuroIntervention 2009;5:206-211

33
Intravascular ultrasound measures of coronary atherosclerosis are associated with the Framingham risk score: an analysis from a global IVUS registry

Marso S, Frutkin A, Mehta S, House J, McCrary J, Klauss V, Lerman A, Leon M, Nair A, Margolis P, Erbel R, Nasu K, Schiele F, Margolis J

EuroIntervention 2009;5:212-218

34
Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON)

Rozenman1 Y, Witzling V, Tamari I, Turkisher V, Kriviski M, Bode C, Henry P, Teiger E, Cebrian A, Stoll H, Spaulding C

EuroIntervention 2009;5:219-223

35
Reproducibility of quantitative optical coherence tomography for stent analysis

Gonzalo N, García-García H, Serruys PW, Commissaris K, Bezerra H, Gobbens P, Costa M, Regar E

EuroIntervention 2009;5:224-232

36
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)

Verheye S, Sarno G, Muller R, Birkemeyer R, Vrints C, Jung W, Agostoni P, van Langenhove G, Haine S, Willems T, Haude M, Grube E, Wijns W

EuroIntervention 2009;5:224-232

37
Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention

Lemos P, Campos C, Falcão J, Ribeiro E, Perin M, Kajita L, Filho E, da Gama M, Horta P, Marchiori G, Spadaro A, Martinez E

EuroIntervention 2009;5:239-243

38
Rapid pacing rotational angiography with three-dimensional reconstruction: use and benefits in structural heart disease interventions This article contains pictures and/or videos

Noble S, Miro J, Yong G, Bonan R, Tardif J, Ibrahim R

EuroIntervention 2009;5:244-249

39
Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels

Ferrero V, Tomai F, Versaci F, Feola M, Proietti I, Rognoni A, Ghini A, Gaspardone A, Vacca G, De Luca L, Vassanelli C, Ribichini F

EuroIntervention 2009;5:250-254

40
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study Alfredo E.

Rodriguez A, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Granillo R, Rodríguez-Granillo G, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios I, Serruys PW

EuroIntervention 2009;5:255-264

41
Use of the Heartrail II catheter as a distal stent delivery device; an extended case series

Mamas M, Eichhofer E, Hendry C, El-Omar M, Clarke B, Neyses L, Fath-Ordoubadi F, Fraser D

EuroIntervention 2009;5:265-271

42
Impact of dye injection on intracoronary pressure

Stoel M, Kandhai-Ragunath J, Van Houwelingen G, von Birgelen C

EuroIntervention 2009;5:272-276

Expert review
43
Coronary stenting in warfarin treated patients

Zahger D, Ilia R

EuroIntervention 2009;5:277-281

Volume 5 Number 2 has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • Cordis, a Johnson & Johnson company
  • Hexacath
  • Medtronic
  • Terumo

Online ISSN 1969-6213 - Print ISSN 1774-024X